266 A phase II study of VP-16 plus ifosfamide plus cisplatin (VIP) plus concurrent radiation therapy (XRT) for previously untreated limited small cell lung cancer (SCLC): A Hoosier Oncology Group (HOG) trial
Keyword(s):
Phase Ii
◽
2009 ◽
Vol 4
(4)
◽
pp. 527-533
◽